| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 276.22B | 285.39B | 292.95B | 243.44B | 206.44B | 198.50B |
| Gross Profit | 28.77B | 29.76B | 28.41B | 20.17B | 12.87B | 9.56B |
| EBITDA | 15.32B | 21.59B | 14.23B | 14.19B | 5.16B | -6.12B |
| Net Income | 9.94B | 11.31B | 5.42B | 5.82B | -2.06B | -13.70B |
Balance Sheet | ||||||
| Total Assets | 160.73B | 173.05B | 183.31B | 170.67B | 159.00B | 151.66B |
| Cash, Cash Equivalents and Short-Term Investments | 41.56B | 43.68B | 39.19B | 34.11B | 32.41B | 29.76B |
| Total Debt | 10.97B | 14.52B | 14.84B | 22.82B | 25.03B | 21.42B |
| Total Liabilities | 68.41B | 74.86B | 87.01B | 84.19B | 79.81B | 72.99B |
| Stockholders Equity | 91.27B | 96.28B | 89.78B | 80.37B | 72.86B | 72.54B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.30B | 14.80B | 239.00M | -4.35B | -6.87B |
| Operating Cash Flow | 0.00 | 9.76B | 18.45B | 3.74B | -354.00M | -1.95B |
| Investing Cash Flow | 0.00 | 3.96B | -2.08B | 6.67B | 2.01B | -6.33B |
| Financing Cash Flow | 0.00 | -9.29B | -13.37B | -10.01B | -812.00M | 5.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥245.08B | 8.29 | ― | 3.36% | 4.89% | 52.78% | |
79 Outperform | ¥422.78B | 11.25 | ― | 1.60% | -2.91% | 103.94% | |
76 Outperform | ¥70.31B | 7.00 | 11.87% | 5.00% | -11.12% | 46.62% | |
71 Outperform | ¥87.14B | 5.34 | ― | 3.88% | -4.13% | 158.47% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥394.26B | 18.50 | 3.70% | 3.42% | 4.24% | 39.02% | |
58 Neutral | ¥202.53B | 16.01 | ― | 4.77% | -4.64% | -39.59% |